These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 8762820)

  • 1. [Comparative study of the antimicrobial activity of pefloxacin, ciprofloxacin, norfloxacin and azithromycin with respect to Strains of Yersinia pseudotuberculosis].
    Zaĭtseva EA; Shubin FN; Besednova NN
    Antibiot Khimioter; 1996 Jan; 41(1):19-21. PubMed ID: 8762820
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Yersinia pseudotuberculosis sensitivity to fluoroquinolones and the efficacy of pefloxacin in experimental pseudotuberculosis].
    Zaĭtseva EA; Shubin FN; Besednova NN
    Zh Mikrobiol Epidemiol Immunobiol; 1997; (5):49-52. PubMed ID: 9432847
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Elimination of virulence plasmids of Yersinia pseudotuberculosis as affected by fluoroquinolones].
    Zaĭtseva EA; Shubin FN; Besednova NN
    Antibiot Khimioter; 1996 Jun; 41(6):34-8. PubMed ID: 9054327
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [The effect of fluoroquinolones on the adhesive properties of different plasmidovars of Yersinia pseudotuberculosis].
    Shubin FN; Zaĭtseva EF; Besednova NN
    Antibiot Khimioter; 2000; 45(5):9-13. PubMed ID: 10862348
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Sensitivity of Yersinia pseudotuberculosis to pefloxacin].
    Zaĭtseva EA; Shubin FN; Besednova NN
    Antibiot Khimioter; 1995 Jul; 40(7):22-4. PubMed ID: 8645054
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparative in vitro activity of ciprofloxacin, ofloxacin and pefloxacin against resistant clinical isolates.
    Periti P; Mazzei T; Nicoletti P
    Chemioterapia; 1987 Apr; 6(2):75-8. PubMed ID: 3474081
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Activity of antibacterial preparations against the causative agent of pseudotuberculosis in vitro].
    Vasil'ev PG; Kalininskiĭ VB; Vasil'ev NT; Iurchenko AV
    Antibiot Khimioter; 1990 Jun; 35(6):29-31. PubMed ID: 2400288
    [TBL] [Abstract][Full Text] [Related]  

  • 8. In vitro activity of pefloxacin compared with five other quinolones on nalidixic acid-resistant proteae species.
    Piccolomini R; Cellini L; Allocati N; Di Girolamo A; Selan L; Scazzocchio F
    Chemioterapia; 1988 Oct; 7(5):287-91. PubMed ID: 3224396
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The role of quinolones in staphylococcal infection.
    Shah PM
    J Chemother; 1989 Aug; 1(4):253-6. PubMed ID: 2809692
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparative antimicrobial activity of lomefloxacin, norfloxacin, ofloxacin, ciprofloxacin and enoxacin against > 500 bacterial isolates.
    Ismaeel NA; Tayeb OS
    Microbios; 1993; 74(300):147-54. PubMed ID: 8396196
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Activity of 5 fluoroquinolones on hospital Gram-negative bacilli with different sensitivities to pefloxacin].
    Aubert G; Puech C; Lucht F; Loboguerrero M; Denis M; Dorche G
    Pathol Biol (Paris); 1989 Oct; 37(8):881-7. PubMed ID: 2515519
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Antimicrobial susceptibility of Yersinia enterocolitica and Yersinia pseudotuberculosis strains isolated from humans in Poland during 2004-2009].
    Szych J; Jakubczak A; Wardak S; Madajczak G
    Med Dosw Mikrobiol; 2009; 61(4):311-9. PubMed ID: 20201320
    [TBL] [Abstract][Full Text] [Related]  

  • 13. In vitro susceptibility of selected veterinary bacterial pathogens to ciprofloxacin, enrofloxacin and norfloxacin.
    Prescott JF; Yielding KM
    Can J Vet Res; 1990 Jan; 54(1):195-7. PubMed ID: 2306672
    [TBL] [Abstract][Full Text] [Related]  

  • 14. In vitro activity of pefloxacin compared to that of quinolones and other antimicrobial agents.
    Neu HC; Chin NX; Labthavikul P; Saha G
    Chemioterapia; 1984 Aug; 3(4):235-41. PubMed ID: 6241847
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparative in vitro activity of fluoroquinolones against Mycobacterium tuberculosis.
    Karak K; De PK
    Indian J Med Res; 1995 Apr; 101():147-9. PubMed ID: 7751043
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [In vitro antibacterial activity of 2 new quinolones: A 56619 (difloxacin) and A 56620. Comparison with pefloxacin, ofloxacin and ciprofloxacin].
    Soussy CJ; Deforges L; Le Van Thoi J; Duval J
    Pathol Biol (Paris); 1987 Jun; 35(5 Pt 2):759-67. PubMed ID: 3309811
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The comparative in vitro activity of twelve 4-quinolone antimicrobials against enteric pathogens.
    O'Hare MD; Felmingham D; Ridgway GL; Grüneberg RN
    Drugs Exp Clin Res; 1985; 11(4):253-7. PubMed ID: 2941257
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Effect of quinolones on mice experimental infection by Plasmodium berghei and their possible therapeutic usefulness].
    Amato Neto V; Braz LM; Campos R; Matsubara L; Silva Mde F; Pinto PL
    Rev Hosp Clin Fac Med Sao Paulo; 1993; 48(3):116-8. PubMed ID: 8248700
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Conjugative R-plasmid resistance of the causative agents of Yersinia infection].
    Gridnev VA; Dziubak VF; Zagoruĭko VG; Gridneva LG; Zaĭnulina ZU
    Antibiot Khimioter; 1990 Feb; 35(2):19-22. PubMed ID: 2337369
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Comparative evaluation of the effectiveness of fluoroquinolones in experimental anthrax infection].
    D'iakov SI; Katsalukha VV; Lebedeva IK; Lukashina AV; Raĭskaia VA
    Antibiot Khimioter; 1994 Jun; 39(6):15-9. PubMed ID: 7848000
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.